The BRCA1 germline pathogenic variant is more likely to be associated with triple-negative BC (TNBC) and the BRCA2 germline pathogenic variant is more often associated with hormone receptor (HR)-positive BC (4). This evidence concerns the gene BRCA2 and breast cancer.